Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line.

This research explores how ketamine, a common horse anesthetic, can impact and potentially reduce cytokine response in horses, particularly focusing on tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) which play a significant role in equine endotoxaemia associated with gastrointestinal issues.

The Premise of the Study

• The study is aimed at understanding the effects of ketamine, an anesthetic commonly used in equine medicine, on the cytokine response in horses. Specifically, it explores the role of ketamine on two prominent cytokines – tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6).
• Cytokines are important proteins released by cells that have a crucial role in cell signalling and immune responses. In equine species, TNF-alpha and IL-6 are associated with endotoxaemia, a serious condition that follows gastrointestinal disorders.
• The research examines the inhibitory effect of ketamine on these cytokines using an equine macrophage cell line (eCAS cells)

Findings of the Study

• Findings of the study suggest that ketamine demonstrates a “cytokine-modulating activity” in horses, specifically in an equine cell line.
• This means that ketamine potentially plays a role in regulating or inhibiting the production and activity of cytokines, particularly TNF-alpha and IL-6.
• The inhibitory effect of ketamine on these cytokines could suggest its beneficial role in the treatment of equine endotoxaemia, a serious condition that develops due to gastrointestinal disorders in horses.

Implications of the Research

• If the inhibitory effect of ketamine on these cytokines in an equine cell line is validated through further study, it could lead to new ways of managing equine endotoxaemia. This is significant, as endotoxaemia is a serious condition often resulting in high morbidity rates in horses.
• The findings highlight that apart from its well-known anaesthetic and analgesic properties, ketamine could potentially have a cytokine-modulating role which could be utilized for therapeutic purposes.
• This research adds to the existing understanding of the multiple ways in which ketamine could potentially be used in equine medicine.